SERA PROGNOSTICS, INC. - Class A Common Stock, par value $0.0001 per share (SERA)
CUSIP: 81749D107
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Class A Common Stock, par value $0.0001 per share
- Shares outstanding
- 38,452,198
- Total 13F shares
- 7,042,648
- Share change
- -1,501,360
- Total reported value
- $8,861,320
- Price per share
- $1.26
- Number of holders
- 29
- Value change
- -$2,401,722
- Number of buys
- 8
- Number of sells
- 19
Quarterly Holders Quick Answers
What is CUSIP 81749D107?
CUSIP 81749D107 identifies SERA - SERA PROGNOSTICS, INC. - Class A Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 81749D107:
Top shareholders of SERA - SERA PROGNOSTICS, INC. - Class A Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO |
13F
|
Company |
6.3%
|
2,416,241
|
$3,866,000 | — | 30 Sep 2022 | |
| Vivo Capital, LLC |
13F
|
Company |
4.8%
|
1,856,011
|
$2,970,000 | — | 30 Sep 2022 | |
| SANDERS MORRIS HARRIS LLC |
13F
|
Company |
3.6%
|
1,389,573
|
$2,223,000 | — | 30 Sep 2022 | |
| Blue Ox Healthcare Partners, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
256,665
|
$1,339,791 | — | 18 Jul 2022 | |
| Douglas Carl Fisher |
3/4/5
|
Chief Business Officer |
—
class O/S missing
|
220,562
|
$1,151,334 | — | 10 Jan 2022 | |
| Fosun International Ltd |
13F
|
Company |
1.4%
|
554,148
|
$887,000 | — | 30 Sep 2022 | |
| Skye Global Management LP |
13F
|
Company |
1.4%
|
526,000
|
$842,000 | — | 30 Sep 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.81%
|
312,350
|
$500,000 | — | 30 Sep 2022 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.63%
|
240,646
|
$385,000 | — | 30 Sep 2022 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0.62%
|
238,099
|
$381,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.55%
|
211,977
|
$339,000 | — | 30 Sep 2022 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.52%
|
201,562
|
$322,000 | — | 30 Sep 2022 | |
| Parian Global Management LP |
13F
|
Company |
0.39%
|
151,698
|
$243,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
123,846
|
$198,000 | — | 30 Sep 2022 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.19%
|
71,552
|
$114,000 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.18%
|
67,340
|
$108,000 | — | 30 Sep 2022 | |
| Requisite Capital Management, LLC |
13F
|
Company |
0.14%
|
55,648
|
$89,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.14%
|
55,619
|
$89,000 | — | 30 Sep 2022 | |
| MAI Capital Management |
13F
|
Company |
0.13%
|
49,503
|
$79,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.08%
|
28,917
|
$46,000 | — | 30 Sep 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.06%
|
23,527
|
$38,000 | — | 30 Sep 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.05%
|
18,108
|
$29,000 | — | 30 Sep 2022 | |
| Lesa Sroufe & Co |
13F
|
Company |
0.04%
|
16,506
|
$26,000 | — | 30 Sep 2022 | |
| ASPIRIANT, LLC |
13F
|
Company |
0.04%
|
16,472
|
$26,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
15,826
|
$25,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
12,558
|
$20,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
10,247
|
$17,000 | — | 30 Sep 2022 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.03%
|
10,000
|
$16,000 | — | 30 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
9,805
|
$16,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
8,128
|
$13,000 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
2,158
|
$3,000 | — | 30 Sep 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
1,310
|
$2,096 | — | 30 Sep 2022 | |
| FMR LLC |
13F
|
Company |
0%
|
1,550
|
$2,000 | — | 30 Sep 2022 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
432
|
$1,000 | — | 30 Sep 2022 | |
| Thomas Garite |
3/4/5
|
VP, Clinical Sciences |
—
class O/S missing
|
10,000
|
— | — | 26 Aug 2021 |
Institutional Holders of SERA PROGNOSTICS, INC. - Class A Common Stock, par value $0.0001 per share (SERA) as of Q4 2022
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.